期刊文献+

汉族冠心病患者MDR1基因C3435T位点多态性与氯吡格雷抵抗的相关性研究 被引量:1

Correlation between MDR1 gene C3435T polymorphism and clopidogrel resistance in patients with coronary heart disease in Ningxia region
下载PDF
导出
摘要 目的探讨宁夏地区汉族人群中,多药耐药基因(MDR1)C3435T位点多态性与冠心病经皮冠状动脉介入治疗(PCI)术后患者发生氯吡格雷抵抗的相关性。方法采集248例研究对象的静脉血,测定二磷酸腺苷(ADP)诱导的血小板聚集率(PAR),根据PAR结果分为氯吡格雷抵抗(CR)组和非氯吡格雷抵抗(NCR)组。应用PCR-RFLP技术检测MDR1基因的C3435T位点核苷酸基因型分布和等位基因频率。结果 C3435T基因可分为CC、CT及TT 3种基因型,在NCR组和CR组中分别占48.3%、41.2%、10.5%和35.5%、32.9%、31.6%,TT基因型的频率在CR组中明显高于NCR组,差异有统计学意义(P<0.05);T等位基因在CR组所占比例明显高于NCR组(48.0%与31.1%,P<0.05)。结论 MDR1基因的C3435T位点TT突变是可能导致宁夏地区汉族人群冠心病PCI术后患者氯吡格雷抵抗发生的因素。 Objective To investigate the correlation between the multidrug resistance gene- 1( MDR1) C3435 T single nucleotide polymorphisms and clopidogrel resistance( CR) in percutaneous coronary intervention( PCI) patients in Ningxia hans population.Methods A total of 248 patients with coronary heart diseases was enrolled. They were divided into CR group and non- CR( NCR)group according to the platelet aggregation rate( PAR). The PAR was detected by optical nephelometry,and PAR ﹥ 50% was defined as CR. The study is a case- control study. Genomic DNA was extracted from the peripheral blood of all patients and Polymerase Chain Reaction( PCR) and Restriction Fragment Length Polymorphism( RFLP) were used to detect the contribution of C3435 T genotypes and alleles. Results The number of CR in this population was 76( 30. 6%). There were 3 kinds of genotypes( CC、CT and TT) of C3435 T and their frequencies in NCR group and CR group were 48. 3% 、41. 2% 、10. 5% and 35. 5% 、32. 9% 、31. 6%. In the two groups,distribution frequency of C3435 T TT genotype and T allele in NCR group was significantly lower than CR group. Further,the difference was statistically significant( P < 0. 05). The genotype frequencies in C3435 T of MDR1 gene conformed well to the Hardy- Weinberg equilibrium in both CR group and NCR group. Conclusion TT genotype of C3435 T gene locus can lead to clopidogrel resistance in PCI patients in Ningxia hans population..
出处 《宁夏医学杂志》 CAS 2016年第6期490-492,共3页 Ningxia Medical Journal
基金 宁夏科技支撑计划项目(2012ZYS212)
关键词 多兹耐药基因 氯吡格雷抵抗 基因多态性 MDR1 Clopidogrel resistance Gene polymorphism
  • 相关文献

参考文献11

  • 1Mega JL,Close SL,Wiviott SD, et al.Genetic variants in ABCB1, CYP2C19, and cardiovascular outcomes following treatment with clopidogrel and prasugrel.. The Lancet . 2010
  • 2Taubert Dirk,von Beckerath Nicolas,Grimberg Gundula,Lazar Andreas,Jung Norma,Goeser Tobias,Kastrati Adnan,Sch?mig Albert,Sch?mig Edgar.Impact of P-glycoprotein on clopidogrel absorption. Clinical Pharmacokinetics . 2006
  • 3Muller I,Besta F,Schulz C,et al.Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thrombosis and Haemostasis . 2003
  • 4冯慧玲,熊玉卿.与P-糖蛋白及MDR1基因关联的药物转运研究现状[J].中国临床药理学杂志,2014,30(11):1062-1064. 被引量:10
  • 5Thuy Anh Nguyen,Jean G. Diodati,Chantal Pharand.Resistance to clopidogrel: A review of the evidence[J]. Journal of the American College of Cardiology . 2005 (8)
  • 6Angiolillo,Dominick J.??Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions(J)Diabetes Care . 2009 (4)
  • 7孙春喜,任澎.基因多态性与阿司匹林和氯吡格雷抵抗相关性的研究进展[J].医学综述,2012,18(20):3356-3358. 被引量:6
  • 8Bonello L,De Labriolle A,Scheinowitz M,et al.Emergence of the concept of platelet reactivity monitoring of response to thienopyridines. Heart . 2009
  • 9Tang K,Ngoi SM,Gwee PC,et al.Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics . 2002
  • 10Simon Tabassome,Verstuyft Céline,Mary-Krause Murielle,Quteineh Lina,Drouet Elodie,Méneveau Nicolas,Steg P Gabriel,Ferrières Jean,Danchin Nicolas,Becquemont Laurent.Genetic determinants of response to clopidogrel and cardiovascular events. The New England Quarterly . 2008

二级参考文献43

  • 1郝盼盼,陈玉国,张运.氯吡格雷抵抗相关因素的研究进展[J].心血管病学进展,2009,30(6):991-994. 被引量:21
  • 2华轶男,谢梅林.阿司匹林抵抗机制及防治研究进展[J].中国药理学通报,2006,22(6):655-659. 被引量:5
  • 3Malek LA,Spiewak M,Filipiak KJ,et al.Persistent platelet activa-tion is related to very early cardiovascular events in patients with a-cute coronary syndromes[J].Kardiol Pol,2007,65(1):40-45.
  • 4Maree AO,Curton RT,Chubb A,et al.Cyelooxygenase-1 haplocytemodulates platelet response to aspirin[J].J Thromb Hacmont,2005,3(10):2340-2345.
  • 5Quick AJ.Salicylates and bleeding:The aspirin tolerance test[J].Am J Medical Sciences,1966,252(3):265-269.
  • 6Pamukcu B.A review of aspirin resistance,definition,possiblemechanisms,detection with platelet function tests,and its clinicaloutcomes[J].J Thromb Thrombolysis,2007,23(3):213-222.
  • 7Mosorjakova D,Paluch Z,Aluslk S.Aspirin resistance[J].BratialLek Listy,2007,108(1):7-13.
  • 8Hillarp A,Palmqvist B,Lethagen S,et al.Mutations within the cy-clooxygenase-1 gene in aspirin non-responders with recurrence ofstroke[J].Thromb Res,2003,112(5/6):75-283.
  • 9Takahashi S,Ushida M,Komine R,et al.Platelet responsiveness toin vitro aspirin is independent of COX-1 and COX-2 protein levelsand polymorphisms[J].Thromb Res,2008,121(4):509-517.
  • 10Jefferson BK,Foster JH,Mccarthy JJ,et al.Aspirin resistance and asingle gene[J].Am J Cardiol,2005,95(6):805-808.

共引文献20

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部